Accredo Health Group INC
Accredo Health Group INC was paid $20.28M by Medicaid between Jan 2018 and Sep 2024, across 9 billing codes. Its largest line is J3285, Injection, treprostinil, 1 mg — 79% of everything it billed.
CORONA, CA 92878
Next to other Durable Medical Equipment & Medical Supplies providers in California
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,051 | $3.95M | |
| 2019 | 1,647 | $3.80M | |
| 2020 | 1,922 | $4.95M | |
| 2021 | 1,542 | $3.89M | |
| 2022 | 1,033 | $1.90M | |
| 2023 | 787 | $893K | |
| 2024incomplete | 363 | $899K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J3285 | Injection, treprostinil, 1 mg | 79% | 1,891 | 1,697 | $16.03M |
| S9347 | Home infusion therapy, uninterrupted, long-term, controlled rate intravenous or subcutaneous infusion therapy (e.g., epoprostenol); administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem | 11% | 2,707 | 1,299 | $2.32M |
| J7686 | Treprostinil, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, 1.74 mg | 7.5% | 445 | 383 | $1.52M |
| J1325 | Injection, epoprostenol, 0.5 mg | <1% | 274 | 185 | $166K |
| K0455 | Infusion pump used for uninterrupted parenteral administration of medication, (e.g., epoprostenol or treprostinol) | <1% | 1,505 | 1,441 | $125K |
| A4222 | Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately) | <1% | 549 | 382 | $92K |
| A4221 | Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately) | <1% | 1,576 | 1,243 | $27K |
| Q0513 | Pharmacy dispensing fee for inhalation drug(s); per 30 days | <1% | 13 | 12 | $3K |
| K0552 | Supplies for external non-insulin drug infusion pump, syringe type cartridge, sterile, each | <1% | 385 | 361 | $2K |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Accredo Health Group INC | Memphis, TN | $165.63M |
| Accredo Health Group INC | Warrendale, PA | $130.92M |
| Accredo Health Group INC | Irving, TX | $27.68M |
| Accredo Health Group INC | Tempe, AZ | $9.15M |
| Accredo Health Group INC | Lenexa, KS | $945K |
| Accredo Health Group INC | Marlborough, MA | $480K |
| Accredo Health Group INC | Las Vegas, NV | $480K |
| Accredo Health Group INC | New Orleans, LA | $266K |
| Accredo Health Group INC | Hoover, AL | $247K |
| Accredo Health Group INC | Greensboro, NC | $243K |
| Accredo Health Group INC | Oklahoma City, OK | $174K |
| Accredo Health Group INC | Novi, MI | $33K |
| Accredo Health Group INC | Pine Brook, NJ | $17K |
| Accredo Health Group INC | Englewood, CO | $6K |
| Accredo Health Group INC | Elmhurst, IL | $3K |
| Accredo Health Group INC | Norcross, GA | $481.79 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.